Advanced Parenteral Drug Delivery Devices Market By Product Type (Pre-fillable Syringes, Wearable Injectors, Pens& Auto-Injectors, Injectors cartridges, hypodermic syringes, IV catheters, Vial Bag Infusion System & Others), By Route of Administration (Intra-arterial & intracardiac, Intradermal, Subcutaneous, Intramuscular, Intraspinal & Others), By Application (Cardiovascular Agents, Central Nervous System Agents, Gastrointestinal Agents, Respiratory Agents, Genito-urinary Agents, Obstetrics & Gynecology Agents, Hormones & Related Agents, Anti-infective Agents & Nutritional Agents), By Distribution Channel (Retail pharmacies, Hospital Pharmacies & Online Pharmacies), By End User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Surgical Centers & Others), By Geography - Global Opportunity Analysis & Industry Forecast, 2022-2027
Advanced Parenteral Drug Delivery Devices Market Overview
The Advanced Parenteral Drug Delivery Devices Market size is forecasted to reach $18.4 billion by 2027 and is expected to grow at a CAGR of 8.6% during the forecast period 2022-2027. Parenteral medication administration is the second most commonly used route of drug administration after oral drug administration. Some of the key components required by the delivery devices include pre-fillable syringe, hypodermic syringe, microneedle patch, injectors cartridge and catheters. As the number of parenteral medications continue to climb, so does the demand for sophisticated drug delivery devices; that provide ease of administration and cost containment. Healthcare systems around the world are feeling the strain as chronic diseases like diabetes, heart disease and COPD have become more common. Many pharmaceutical companies are responding by inventing parenteral drug delivery systems such as autoinjectors that patients can use to self-administer the drugs. This trend is posing a number of business issues, such as the need for additional patient research, the development of more sophisticated equipment to accommodate novel medicine formulations and improved training to boost end-user confidence. As biologics lose their patents, the availability of biosimilars and generics has increased the demand for autoinjectors. The next step for drug-delivery device innovators will be to improve the convenience and intuitiveness of systems that support ambulatory use and possibly personalized medicine while also improving patient outcomes, lowering the cost of care and gaining reimbursement.
Advanced Parenteral Drug Delivery Devices Market Report Coverage
The “Advanced Parenteral Drug Delivery Devices Market Report - Forecast (2022-2027)” by Industry ARC, covers an in-depth analysis of the following segments in the Advanced Parenteral Drug Delivery Devices Market.
- Parenteral products are a significant growth driver in today's brisk global biopharma market. A new generation of connected autoinjectors, infusion pumps and other drug delivery technologies combine personalized dosing with data collection and reporting. These delivery systems make dosing easier while also providing a new level of digital visibility and insight into each course of treatment.
- During the pandemic, remote care management has increased and patients are keen to stay at home as much as feasible. This puts more pressure on biopharma companies to not only introduce new medicines faster and more efficiently than ever before, but also to incorporate features into those new products that make self-administered treatments as safe, effective and convenient as possible.
- Advanced Parenteral Drug Delivery Devices Market Detailed Analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Advanced Parenteral Drug Delivery Devices Market report.
Advanced Parenteral Drug Delivery Devices Market Segment Analysis - by Product Type
Advanced Parenteral Drug Delivery Devices Market based on product type can be segmented into Pre-fillable Syringes, Wearable Injectors, Pens & Auto-Injectors, Injectors cartridges, hypodermic syringes, IV catheters, Vial Bag Infusion systems and Others. The Pens & Auto-injectors segment held the largest share in the Advanced Parenteral Drug Delivery Devices Market in 2021 and is estimated to grow at a CAGR of 7.8% during the forecast period 2022-2027. Auto-injectors and pen injectors have become the new standard for injectable drug-delivery systems in this rapidly growing market. Because of their simplicity, dependability and ability to be administered directly by the patient without the assistance of a physician, their popularity has skyrocketed.
However, Pre-filled syringes are estimated to be the fastest-growing segment and will witness the highest CAGR during the forecast period 2022-2027. These pre-filed products are one of the fastest-growing markets in the medical device industry, helping to solve the majority of the disadvantages associated with parenteral administration. In fact, the market for prefilled syringes is expected to double in size over the next ten years.
Advanced Parenteral Drug Delivery Devices Market Segment Analysis - by Distribution Channel
Advanced Parenteral Drug Delivery Devices Market based on distribution channel can be segmented into retail pharmacies, Hospital Pharmacies & Online Pharmacies. The retail Pharmacies segment has the largest share in the Advanced Parenteral Drug Delivery Devices Market in 2021 and is estimated to grow at a CAGR of 6.9% during the forecast period 2022-2027. The subcutaneous drug delivery devices allow patients to self-administer their medications as needed. The easy availability, the widespread presence of retail pharmacies, increased awareness of subcutaneous drug delivery devices and rising health consciousness among the population have all contributed to the global growth of the retail pharmacies segment.
However, Online pharmacies are rapidly gaining popularity among consumers. The growing popularity of online pharmacy platforms and increased internet penetration is driving the market growth. The easy-to-use interface of online pharmacy platforms, simple payment options and quick home delivery are the major features offered by online pharmacies that are expected to drive growth during the forecast period.
Advanced Parenteral Drug Delivery Devices Market Segment Analysis - by Geography
The Global Demand for Advanced Parenteral Drug Delivery Devices Market based on Geography can be segmented into North America, South America, Europe, Asia-Pacific and Rest of the World. The North American region dominated the Advanced Parenteral Drug Delivery Devices Market in 2021 with a market share of 40%. This is owing to the rising prevalence of chronic disease along with the increasing number of geriatric populations. A study by the Centers for Disease Control and Prevention reveals that more than 50% of people in North America suffer from a particular type of Chronic disease. Furthermore, the rising prevalence of various chronic diseases has resulted in a surge in the population's demand for drugs and drug delivery devices. Approximately 60% of the US population suffers from one or more chronic illnesses.
However, Asia-Pacific is poised to be the fastest-growing segment during the forecast period of 2022-2027, owing to the rapid improvement in healthcare systems. During the forecast period, Asia-Pacific is expected to be the most opportunistic segment. This is primarily due to the rapidly-growing diabetic population in the region as a result of people's unhealthy eating habits. According to the International Diabetes Federation, Asia is home to roughly 60% of the world's diabetic population.
Advanced Parenteral Drug Delivery Devices Market Drivers
The prevalence of chronic diseases and the increasing use of vaccinations is fueling the Market Growth
According to the World Health Organization, Cardiovascular diseases account for most deaths, 17.9 million people annually, followed by cancers (9.3 million), respiratory diseases (4.1 million), and diabetes (1.5 million). According to the International Agency for Research on Cancer, approximately 19.3 million new cancer cases were reported in 2020 and this figure is expected to rise to 28.4 million by 2040. The rapid growth of the biopharmaceutical industry as well as the development of various innovative biologics and biosimilar drugs; has exponentially supported the growth of the parenteral drug delivery devices market. Biotechnology advancements, digital solutions and the ongoing impact of COVID-19 are all having a significant impact on the advanced parenteral drug delivery devices market. Trends that emerged in 2020 and 2021 are likely to evolve and have become more significant in 2022. This includes the development of biosimilars as well as the enhancement of bioprocesses.
Novel trends in parenteral drug delivery devices are boosting the product demand
The healthcare industry has become increasingly digitalized, with the widespread adoption of connected devices in laboratories and hospitals, electronic health records (EHR), and tablets and smartphones to assist healthcare professionals. According to Cigna, 60% of consumers expect that their digital healthcare experience should be an exact replica of their retail healthcare experience. Further, 57% of consumers are open to remote monitoring of ongoing health issues through at-home devices. The market for advanced parenteral drug delivery devices is expected to rise due to increased investment from key players in the development of novel modes of administration for new medications. When compared to old medication delivery methods, modern drug delivery devices are far more advanced. Many of these gadgets are loaded with electronics and sensors that track dose delivery and timing while also providing immediate feedback to patients. The broad availability of low-cost connections such as near-universal access to technology like smartphones and Bluetooth, has ushered new prospects in the healthcare industry.
Advanced Parenteral Drug Delivery Devices Market Challenges
Rise in Biologics Brings Challenges to the market
The constraints of developing devices capable of delivering highly viscous biologic drug formulations at high volumes are limiting the industry expansion. High load during storage, device size and high-cost solutions are the few factors challenging the growth of the market. The main consideration is generating the high injection forces required. Integration of the electronics and the componentry into the overall mechanical design is a significant challenge. This requires a strong systems-level engineering approach to ensure a robust device at production volume. Further, non-adherence to medication schedules may further hamper the product demand. According to Contract Pharma, in 2022, non-adherence to medication is estimated to cost U.S., drug manufacturers over $250 billion annually and global drug companies over $637 billion annually.
Advanced Parenteral Drug Delivery Devices Industry Outlook
Product Launch and Acquisitions were the key strategies adopted by players in the Advanced Parenteral Drug Delivery Devices Market. In 2022, the Advanced Parenteral Drug Delivery Devices Market share is consolidated by the top 10 players present in the market. Advanced Parenteral Drug Delivery Devices market's top 10 companies include:
- Consort Medical Plc.
- Eli Lilly and Company
- Novo Nordisk
- Insulet Corporation
- Enable Injections
- Amgen Inc.
- Becton, Dickinson and Company
- Sanofi S.A.
- Merck &Co. Inc.
- AstraZeneca Plc.
- In October 2021, Owen Mumford Pharmaceutical Services, a division of Owen Mumford launched its new Aidaptus auto-injector platform following the successful completion of development. Aidaptus is a two-step, spring-powered, single-use auto-injector with a design that accommodates both 1mL and 2.25 mL prefilled glass syringes in the same base device.
- In April 2021, Medtronic introduced a wearable injector that can be worn by the patients for 7 days for the treatment of diabetes.
- In April 2020, Sanofi acquired the US FDA approval for its new prefilled pen, named Dupixent which serves asthma, chronic rhinosinusitis and atopic dermatitis patients with homecare service.
Report Code: HCR 58467
Report Code: HCR 0023
Report Code: HCR 0718
For more Lifesciences and Healthcare Market reports, please click here